SHAREHOLDER ALERT: GRABAR LAW OFFICE INVESTIGATES INTEGRA LIFESCIENCES HOLDINGS CORPORATION (IART)
- 53
Have You Continuously Held Integra LifeSciences Shares Since Prior to March 11, 2019? You May Have Legal Options at No Cost to You.
Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating alleged corporate misconduct at Integra LifeSciences Holdings Corporation (NASDAQ: IART). If you have held Integra shares since before March 11, 2019, you may have the right to:
- Demand corporate reforms to improve governance.
- Recover funds spent by company defending class action litigation.
- Receive a court-approved incentive award, all at no cost to you.
Learn more today: https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/
Or contact Joshua Grabar at [email protected] or call 267-507-6085 for a free consultation.
What Is the Investigation About?
A recent securities fraud class action complaint alleges the following misconduct by Integra's officers and directors:
- Misleading statements claiming Integra was on track to expand the market for SurgiMend by securing FDA approval for use in post-mastectomy reconstruction.
- Artificially inflating stock prices through these misrepresentations.
On May 23, 2023, Integra issued a recall of all products manufactured at its Boston Facility from March 1, 2018, to May 22, 2023. According to the company:
- The Boston Facility failed to meet good manufacturing practices by releasing products with unsafe levels of bacterial endotoxins.
- All production at the Boston Facility was paused, and the company had to revise its second-quarter 2023 guidance, reducing revenue expectations by 6% and adjusted earnings per diluted share by 26%.
- Integra also reported a $22 million impairment charge due to inventory write-offs.
What Can Long-Term Shareholders Do?
If you have continuously held Integra LifeSciences (IART) shares since before March 11, 2019, you may be able to:
- Seek corporate reforms to ensure better governance.
- Recover corporate funds spent on defending litigation.
- Qualify for a court-approved incentive award, at no cost to you.
Take Action Today to Protect Your Rights
Visit: https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/.
Or contact Joshua Grabar directly:
- Phone: 267-507-6085
- Email: [email protected]
#IntegraLifeSciences #IART $IART #SecuritiesFraud #ShareholderAlert #InvestorRights #CorporateGovernance #ClassAction #GrabarLaw #FDARecall #StockMarket #LegalAction
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226580
- L'Arabia Saudita ospiterà il Forum multilaterale sulla politica industriale (MIPF) nell'ottobre 2024
- Aleph acquisisce una quota di controllo del capitale azionario di Localpayment e punta a un mercato dei pagamenti digitali da 1,4 trilioni di dollari
- Fnac Darty : Progetto di acquisizione di Unieuro : Condizione Soglia Minima Ridotta
- EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation
- Piramal Pharma pubblica il suo rapporto sulla sostenibilità per l'anno fiscale 2023-24 sul tema "Costruire resilienza per un futuro sostenibile"
- EQS-News: Il World Green Economy Summit 2024 Ospita una Tavola Rotonda Ministeriale di Altissimo Livello